Burt Reynolds Wikipedia
These searches extend to 1996 because this corresponds to the last time the USPSTF evaluated similar data and represents a period when practice was shifting to digital mammography in the United States. The contextual questions have a shorter time period for searches because they require current data. Thus, current beta-cell mitogens have therapeutic limitations because they have a low therapeutic window.
1153. McElroy JA, Remington PL, Gangnon RE, et al. Identifying geographic disparities in the early detection of breast cancer using a geographic information system. 1147. McCarty CA, Reding DJ, Commins J, et al. Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Uhry Z, Hedelin G, Colonna M, et al. Modelling the effect of breast cancer screening on related mortality using French data. 1766. Tice JA, O’Meara ES, Weaver DL, et al. Benign breast disease, mammographic breast density, and the risk of breast cancer. 1759.
45 This is referred to as early neurological deterioration, which, if it persists, is termed stroke progression and reflects secondary brain injury. The Food and Drug Administration in the United States recently approved the combination of ticagrelor plus aspirin for secondary stroke prevention. In some Asian countries, another drug with antiplatelet activity, cilostazol, is approved for use and widely employed. In the rivaroxaban-plus-aspirin group, mortality was also lower (HR 0.82; 95% CI, 0.71 to 0.96), as was IS (HR 0.51; 95% CI 0.38–0.68) compared with the aspirin-alone group.
Real-time virtual sonography, a coordinated sonography and MRI system that uses magnetic navigation, improves the sonographic identification of enhancing lesions on breast MRI. 1268. Nakagawa T, Hara T, Fujita H, et al.
1219. Moon JH, Kim HH, Shin HJ, et al. Supplemental use of optical diffusion breast imaging for differentiation between benign and malignant breast lesions. naltrexone weight loss reddit 1210. Miyake T, Shimazu K, Ohashi H, et al. Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. Bennett IC, Muller J, Cockburn L, et al. Outcomes of multimodality breast screening for women at increased risk of familial breast cancer. Barnett JB. The relationship between obesity and breast cancer risk and mortality. Bailey SL, Sigal BM, Plevritis SK. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged years. Azavedo E, Zackrisson S, Mejare I, et al.
Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in italy by analyses based on calendar time and time since screening activation. Cowan WK, Angus B, Gray JC, et al. A study of interval breast cancer within the NHS breast screening programme.
Gill KS, Yankaskas BC. Screening mammography performance and cancer detection among black women and white women in community practice. Gilbert FJ. New screening techniques for breast cancer . Fielder H, Rogers C, Gower-Thomas K, et al. Results from 10 years of breast screening in Wales.
Osako T, Iwase T, Takahashi K, et al. Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years. 1353. 1340. Ondrusova M, Muzik J, Durdik S, et al.